Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1139 Results

Title
Intervention Indication Therapeutic Area Year Actions
CC-486 for angioimmunoblastic T-cell lymphoma Azacitidine (Vidaza; CC-486) Angioimmunoblastic T-cell Lymphoma (AITL) Haematological Cancer and Lymphomas 2020 View  |  Download
Carotuximab in combination with Pazopanib for Advanced Angiosarcoma Carotuximab (TRC105; DE-122) , Pazopanib (Votrient; GW 786034; pazopanib hydrochloride) Soft tissue sarcoma Sarcoma 2018 View  |  Download
Carfilzomib in addition to daratumumab and dexamethasone for relapsed and/or refractory multiple myeloma Carfilzomib (Kyprolis; ONO-7057) , Daratumumab (Darzalex; JNJ-54767414) , Dexamethasone (dexamethasone sodium metasulfobenzoate) Multiple myeloma (MM) Haematological Cancer and Lymphomas 2019 View  |  Download
Capmatinib for advanced non-small cell lung cancer Capmatinib (INC280) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2021 View  |  Download
Capivasertib with paclitaxel for previously untreated locally advanced or metastatic triple-negative breast cancer Capivasertib , Paclitaxel (Taxol; paclitaxel albumin) Breast cancer Breast Cancer 2023 View  |  Download
Capivasertib with fulvestrant for HR+/HER2- locally advanced or metastatic breast cancer Capivasertib , Fulvestrant (Faslodex) Breast cancer Breast Cancer 2023 View  |  Download
Cannabidiol in a pharmaceutical formulation (Epidiolex; GWP42003-P) for Lennox-Gastaut syndrome in children and adults Cannabidiol (BRCX-014; Epidiolex; GW42003; GWP42003; GWP-42003; PG-DN-20WS) Lennox-Gastaut syndrome Neurology 2017 View  |  Download
Cannabidiol (Epidiolex) for Tuberous Sclerosis Complex - add-on therapy Cannabidiol (BRCX-014; Epidiolex; GW42003; GWP42003; GWP-42003; PG-DN-20WS) Tuberous sclerosis Genetic Disorders 2017 View  |  Download
Canakinumab in addition to pembrolizumab and platinum-based chemotherapy for locally advanced or metastatic non-small-cell lung cancer (NSCLC) Canakinumab (Ilaris; ACZ885) , Pembrolizumab (Keytruda; MK-3475) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2021 View  |  Download
Canakinumab for Schnitzler syndrome Canakinumab (Ilaris; ACZ885) Schnitzler syndrome Immunology 2021 View  |  Download
1 2 92 93 94 95 96 113 114
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications